Nuclear factor‐κB as a molecular target for migraine therapy

@article{Reuter2002NuclearFA,
  title={Nuclear factor‐κB as a molecular target for migraine therapy},
  author={U. Reuter and A. Chiarugi and H. Bolay and M. Moskowitz},
  journal={Annals of Neurology},
  year={2002},
  volume={51}
}
  • U. Reuter, A. Chiarugi, +1 author M. Moskowitz
  • Published 2002
  • Medicine
  • Annals of Neurology
    • Nitric oxide (NO) generated from inducible NO synthase (iNOS) participates in immune and inflammatory responses in many tissues. The NO donor glyceryl trinitrate (GTN) provokes delayed migraine attacks when infused into migraineurs and also causes iNOS expression and delayed inflammation within rodent dura mater. Sodium nitroprusside, an NO donor as well, also increases iNOS expression. Because inflammation and iNOS are potential therapeutic targets, we examined transcriptional regulation of… CONTINUE READING
    View on Wiley
    97 Citations
    Background Citations
    20
    Methods Citations
    3
    Results Citations
    1
    97 Citations
    Citation Type

    Citation Type

    Inhibition of the PKCγ-ε Pathway Relieves from Meningeal Nociception in an Animal Model: An Innovative Perspective for Migraine Therapy?
    • 11
    Targeted Nitric Oxide Synthase Inhibitors for Migraine
    • 30
    • PDF
    beta-MSH inhibits brain inflammation via MC3/4 receptors and impaired NF-κB signaling
    • 13
    Tetrandrine attenuates NF-ĸB activation in trigeminal ganglia by blocking calcium channel in a rat model of migraine
    • 2
    The IKK‐NF‐κB pathway: a source for novel molecular drug targets in pain therapy?
    • 143
    • PDF
    Differential Effects of Corticosteroids on The Expression of Cyclooxygenase-2, Tumour Necrosis Factor-Alpha and Matrix Metalloproteinase-9 in An Animal Model of Migraine
    • 27
    Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine.
    • 44
    Parthenolide Inhibits IκB Kinase, NF-κB Activation, and Inflammatory Response in Cystic Fibrosis Cells and Mice
    • 99
    Parthenolide Inhibits the LPS‐induced Secretion of IL‐6 and TNF‐α and NF‐κB Nuclear Translocation in BV‐2 Microglia
    • 49
    The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat
    • 18
    • PDF

    References

    SHOWING 1-10 OF 60 REFERENCES
    Delayed inflammation in rat meninges: implications for migraine pathophysiology.
    • 268
    • PDF
    Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*)
    • 649
    • PDF
    Biphasic Regulation of NF-κB Activity Underlies the Pro- and Anti-Inflammatory Actions of Nitric Oxide1
    • 292
    • PDF
    Co‐stimulatory effect of nitric oxide on endothelial NF‐κB implies a physiological self‐amplifying mechanism
    • 108
    Multiple NF-κB Enhancer Elements Regulate Cytokine Induction of the Human Inducible Nitric Oxide Synthase Gene*
    • 407
    • PDF
    Feedback inhibition of nitric oxide synthase activity by nitric oxide
    • 403
    Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.
    • 266
    Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.
    • 3,654
    The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
    • 1,411
    Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages.
    • 45